Neurogene Inc. Common Stock Shares Outstanding

• Neurogene Inc. showed an increase of +4.3% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from Neurogene Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
• XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 13 years of available data (2013 to 2025), Neurogene Inc.'s Common Stock Shares Outstanding has grown by 5,033.4%.
• Historical annual values: Fiscal year 2025: 15.49 million shares | Fiscal year 2024: 14.85 million shares | Fiscal year 2023: 12.82 million shares | Fiscal year 2022: 0 shares | Fiscal year 2021: 42.46 million shares | Fiscal year 2020: 42.20 million shares | Fiscal year 2019: 38.00 million shares | Fiscal year 2018: 23.54 million shares | Fiscal year 2017: 23.47 million shares | Fiscal year 2016: 23.42 million shares | Fiscal year 2015: 17.21 million shares | Fiscal year 2014: 10.70 million shares | Fiscal year 2013: 301,745 shares.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026